As the healthcare profession continues to face challenges with antibiotic resistance, drugmakers are developing novel antibiotics that will be effective against some of the worst infections. One drugmaker submitted New Drug Applications (NDAs) for approval of IV and oral delafloxacin (Baxdela) to FDA.
Despite improvements in the rates of healthcare associated infections in recent years, the Centers for Disease Control and Prevention says healthcare facilities still have more work to do to prevent sick patients from becoming sicker.
A new study reveals that toxin-producing bacteria like staphylococcus may fuel CTCL; therefore, antibacterial treatment may slow disease progression. Findings could one day change how you treat patients.
Staphylococcus aureus plays an important role in the pathogenesis and course of atopic dermatitis. Compared to the normal pediatric population, atopic patients are especially susceptible to colonization and recurrent infections of S aureus.
Studies are available that show promising application of tea tree oil for various dermatologic infections such as bacterial and fungal conditions and molluscum as well as inflammatory conditions such as acne